Genetic and genomic tools for zebrafish research: The NIH zebrafish initiative
β Scribed by Rebekah S. Rasooly; Deborah Henken; Nancy Freeman; Laurie Tompkins; David Badman; Josephine Briggs; A. Tyl Hewitt
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 265 KB
- Volume
- 228
- Category
- Article
- ISSN
- 1058-8388
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The National Institutes of Health (NIH) has been a leading advocate of the zebrafish as a model organism for the study of vertebrate development, physiology, and disease. Genomic tools, developed with the support of NIH funding, have made zebrafish even more attractive as a genetic system and have stimulated research using this model. The NIH continues to provide support for new and existing community resources, such as the Zebrafish International Resource Center and the Zebrafish Information Network, research tool development and mutant screens, and a wide array of investigatorβinitiated studies that are using zebrafish to elucidate many aspects of vertebrate biology. Developmental Dynamics, 2003. Published 2003 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract The zebrafish, originally an object of study as an inexpensive and prolific vertebrate embryological model with a plethora of genetic tricks, has over the past decade moved to largeβscale chemical mutagenesis and recently came of age as a high throughput transgenic model with a sequence
## Schizophrenia has a complex pattern of inheritance, indicative of interactions among multiple genes and environmental factors. The detection and replication of specific susceptibility loci for such complex disorders are facilitated by the availability of large samples of affected sib pairs and
We report on an initial genome screen of 540 individuals from 97 families collected as part of the NIMH Genetics Initiative Bipolar Group. Among the individuals studied, 232 were diagnosed with bipolar (BP) I, 72 with BPII, 88 with major depressive disorderrecurrent type (UPR), and 32 with schizoaff
## Abstract We performed linkage analysis for age at onset (AAO) in the total Alzheimer's disease (AD) NIMH sample (Nβ=β437 families). Families were subset as lateβonset (320 families, AAO β₯65) and early/mixed (117 families, at least 1 member with 50< AAO <65). Treating AAO as a censored trait, we